Follow
Sheema Khan
Sheema Khan
University of Tennessee Health Science Center, Memphis
Verified email at uthsc.edu - Homepage
Title
Cited by
Cited by
Year
Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with …
F Malik, A Kumar, S Bhushan, S Khan, A Bhatia, KA Suri, GN Qazi, ...
Apoptosis 12, 2115-2133, 2007
2882007
Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer
MM Yallapu, S Khan, DM Maher, MC Ebeling, V Sundram, N Chauhan, ...
Biomaterials 35 (30), 8635-8648, 2014
2852014
Curcumin Nanoformulation for Cervical Cancer Treatment.
M Zaman, N Chauhan, murali Yallapu Mohan, R Gara, D Maher, S Kumari, ...
Scientific Reports 6, 20051, 2016
1902016
Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles
MM Yallapu, N Chauhan, SF Othman, V Khalilzad-Sharghi, MC Ebeling, ...
Biomaterials 46, 1-12, 2015
1762015
Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment
MM Yallapu, MC Ebeling, S Khan, V Sundram, N Chauhan, BK Gupta, ...
Molecular cancer therapeutics 12 (8), 1471-1480, 2013
1672013
PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer
Prashanth K.B. Nagesh, Nia R. Johnson, Vijaya K.N. Boya, Pallabita Chowdhury ...
Colloids Surf B Biointerfaces 144, 8-20, 2016
1282016
A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4
B Rah, H Amin, K Yousuf, S Khan, G Jamwal, D Mukherjee, A Goswami
Public Library of Science 7 (9), e44039, 2012
1222012
MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer
S Khan, MC Ebeling, MS Zaman, M Sikander, MM Yallapu, N Chauhan, ...
Oncotarget 5 (17), 7599, 2014
1152014
Nanoways to overcome docetaxel resistance in prostate cancer
A Ganju, MM Yallapu, S Khan, SW Behrman, SC Chauhan, M Jaggi
Drug Resistance Updates 17 (1-2), 13-23, 2014
1022014
Targeting microRNAs in pancreatic cancer: microplayers in the big game
S Khan, Ansarullah, D Kumar, M Jaggi, SC Chauhan
Cancer research 73 (22), 6541-6547, 2013
922013
Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
MS Zaman, DM Maher, S Khan, M Jaggi, SC Chauhan
Journal of ovarian research 5, 1-11, 2012
892012
Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer
CSC Khan Sheema, Ebeling Mara , Chauhan Neeraj, Thompson PA, Gara RK, Ganju ...
Cancer Research 75 (1), 2292-304, 2015
822015
Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity
S Khan, F Malik, KA Suri, J Singh
Vaccine 27 (43), 6080-6087, 2009
652009
The roles of cellular nanomechanics in cancer
CSC Yallapu MM, Katti KS, Katti DR, Mishra SR, Khan S, Jaggi M
Med Res Rev 35 (1), 198-223, 2015
572015
Nanoparticle formulation of ormeloxifene for pancreatic cancer
CSC Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT3 ...
Biomaterials 53, 731-43, 2015
522015
Restitution of Tumor Suppressor microRNA-145 using Magnetic Nanoformulation for Pancreatic Cancer Therapy
SC Saini Setua, Sheema Khan, Murali M. Yallapu, Stephen W. Behrman, Mohammed ...
Journal of Gastrointestinal Surgery, 2016
45*2016
A cyano analogue of boswellic acid induces crosstalk between p53/PUMA/Bax and telomerase that stages the human papillomavirus type 18 positive HeLa cells to apoptotic death
S Khan, R Chib, BA Shah, ZA Wani, N Dhar, DM Mondhe, S Lattoo, ...
European journal of pharmacology 660 (2-3), 241-248, 2011
372011
MUC13 Interaction with Receptor Tyrosine Kinase HER2 Drives Pancreatic Ductal Adenocarcinoma Progression
Oncogene, 1-10, 2016
36*2016
A comparative study of proapoptotic potential of cyano analogues of boswellic acid and 11-keto-boswellic acid
R Kaur, S Khan, R Chib, T Kaur, PR Sharma, J Singh, BA Shah, ...
European journal of medicinal chemistry 46 (4), 1356-1366, 2011
352011
Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing …
FL Hakkim, HA Bakshi, S Khan, M Nasef, R Farzand, S Sam, L Rashan, ...
Oncotarget 10 (37), 3472, 2019
332019
The system can't perform the operation now. Try again later.
Articles 1–20